Subsequent Events (Details) - Fabric Genomics $ / shares in Units, $ in Millions |
3 Months Ended | |
|---|---|---|
|
Apr. 15, 2025
USD ($)
day
$ / shares
|
Mar. 31, 2025
USD ($)
|
|
| Subsequent Event [Line Items] | ||
| Transaction costs | $ 1.2 | |
| Subsequent Event | ||
| Subsequent Event [Line Items] | ||
| Maximum aggregate amount of cash consideration | $ 33.0 | |
| Weighted average price of shares acquired (in shares) | $ / shares | $ 93.0318 | |
| Number of trading days | day | 30 | |
| Subsequent Event | First Milestone Payment | ||
| Subsequent Event [Line Items] | ||
| Cash payment | $ 10.5 | |
| Contingent amount | $ 6.0 | |
| Gross margin (as a percent) | 69.00% | |
| Amount obtained by multiplying milestone payment | $ 7.0 | |
| Amount obtained by dividing the quotient of milestone payment | 8.0 | |
| Subsequent Event | Second Milestone Payment | ||
| Subsequent Event [Line Items] | ||
| Cash payment | 7.5 | |
| Contingent amount | $ 9.0 | |
| Gross margin (as a percent) | 69.00% | |
| Amount obtained by multiplying milestone payment | $ 5.0 | |
| Amount obtained by dividing the quotient of milestone payment | $ 12.0 |
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Business Acquisition, Number Of Trading Days No definition available.
|
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Amount Divided By No definition available.
|
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Amount Multiplier No definition available.
|
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Gross Margin Percentage Threshold No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|